vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT
· Real-Time Price · USD
15.46
1.43 (10.19%)
At close: Aug 15, 2025, 3:58 PM
15.73
1.75%
After-hours: Aug 15, 2025, 04:10 PM EDT
vTv Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 17K | n/a | n/a | 1M | -9K | n/a | 9K | n/a | 9K | n/a | 9K | 2M | 9K | 3M | 9K | 987K |
Cost of Revenue | 3K | 9K | 22K | 22K | 23K | 22K | 23K | 22K | 23K | 22K | 23K | 24K | 88K | 23K | 5K | 2.38M | 2.44M | 3.1M |
Gross Profit | -3K | -9K | -5K | -22K | -23K | 978K | -23K | -22K | -14K | -22K | -14K | -24K | -79K | 1.98M | 4K | 618K | -2.43M | -2.12M |
Operating Income | -7.72M | -6.5M | -4.89M | -6.51M | -7.16M | -5.63M | -4.71M | -5.37M | -8M | -7.43M | -6.34M | -5.69M | -4.03M | -6.48M | -11.11M | -1.6M | -4.67M | -4.28M |
Interest Income | 275K | 331K | 429K | 504K | 553K | 79K | 88K | 131K | 153K | 100K | 152K | 150K | 50K | n/a | n/a | n/a | n/a | 1K |
Pretax Income | -7.38M | -6.22M | -4.44M | -5.84M | -6.41M | -5.92M | -4.44M | -8.54M | -7.21M | -5.77M | -6.09M | -5.47M | -4.09M | -9.22M | -9.48M | -1.36M | -841K | -5.93M |
Net Income | -6.05M | -5.09M | -3.63M | -4.78M | -5.18M | -4.87M | -3.48M | -6.65M | -5.62M | -4.5M | -5.89M | -4.26M | -3.15M | -9.42M | -7.05M | -1.09M | -608K | -4.24M |
Selling & General & Admin | 3.62M | 3.67M | 2.67M | 3.28M | 3.72M | 3.98M | 2.57M | 2.54M | 3.31M | 3.48M | 2.39M | 2.63M | 1.83M | 5.35M | 5.72M | 2.22M | 2.24M | 2.16M |
Research & Development | 4.1M | 2.83M | 2.23M | 3.22M | 3.44M | 2.63M | 2.14M | 2.82M | 4.69M | 3.94M | 3.96M | 3.06M | 2.21M | 3.13M | 5.4M | 2.38M | 2.44M | 3.1M |
Other Expenses | n/a | n/a | -22K | n/a | n/a | n/a | -23K | n/a | n/a | n/a | n/a | n/a | -114K | n/a | n/a | n/a | n/a | -1.65M |
Operating Expenses | 7.72M | 6.5M | 4.89M | 6.51M | 7.16M | 6.61M | 4.68M | 5.37M | 8M | 7.43M | 6.35M | 5.69M | 4.04M | 8.48M | 11.12M | 4.6M | 4.68M | 5.27M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 7K | 4K | 2K | n/a | 6K | 8K | n/a | 1K | 6K | 6K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 7.72M | 6.5M | 4.91M | 6.51M | 7.16M | 6.63M | 4.71M | 5.37M | 8M | 7.43M | 6.35M | 5.69M | 4.04M | 8.48M | 11.12M | 4.6M | 4.68M | 5.27M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 100K | n/a | n/a | n/a | n/a | -199.8K | n/a | n/a | 200K | n/a | 100K | n/a | 15K |
Shares Outstanding (Basic) | 6.59M | 6.58M | 5.77M | 5.46M | 6.4M | 4.14M | 2.08M | 2.04M | 2.04M | 2.04M | 2.04M | 2.01M | 1.76M | 1.67M | 1.67M | 1.53M | 1.47M | 1.41M |
Shares Outstanding (Diluted) | 6.59M | 6.58M | 5.77M | 5.46M | 6.4M | 4.14M | 2.08M | 2.04M | 2.04M | 2.04M | 2.04M | 2.01M | 1.76M | 1.67M | 1.67M | 1.53M | 1.47M | 1.41M |
EPS (Basic) | -0.92 | -0.77 | -0.63 | -0.88 | -0.81 | -1.17 | -1.67 | -3.27 | -2.76 | -2.21 | -2.89 | -2.12 | -1.79 | -5.63 | -4.22 | -0.71 | -0.41 | -3 |
EPS (Diluted) | -0.92 | -0.77 | -0.63 | -0.88 | -0.81 | -1.17 | -1.67 | -3.27 | -2.76 | -2.21 | -2.89 | -2.12 | -1.79 | -5.63 | -4.22 | -0.71 | -0.41 | -3 |
EBITDA | -7.38M | -6.21M | -4.42M | -5.82M | -6.39M | -5.61M | -4.41M | -8.51M | -7.19M | -7.41M | -6.06M | -5.44M | -4.07M | -9.2M | -9.46M | -1.34M | -819K | -5.9M |
EBIT | -7.38M | -6.22M | -4.44M | -5.84M | -6.41M | -5.63M | -4.43M | -8.54M | -7.21M | -7.43M | -6.08M | -5.46M | -4.09M | -9.22M | -9.48M | -1.36M | -841K | -5.93M |
Depreciation & Amortization | 3K | 9K | 22K | 22K | 23K | 22K | 23K | 22K | 23K | 22K | 23K | 24K | 22K | 23K | 22K | 22K | 22K | 23K |